Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 26, 2005
Grant Date -
Dec 12, 2002
app pub date -
Jun 10, 2002
filing date -
Jun 11, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Androst-5-ene-3.beta.,17.beta. diol is used to treat or reduce the likelihood of acquiring osteoporosis or menopausal symptoms, or other diseases affected by estrogen receptor activity, and for conditions which respond well to DHEA treatment, but where a higher ratio of estrogenic to androgenic effects is desired. Combination therapies are included, as are kits and pharmaceutical compositions for providing the active ingredients of claimed methods and combinations.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully